Amgen amends Prolia offer


changes ahead sign
While discounts may provide more incentive for pharmacies to sign up, the Guild says it will continue to oppose exclusive direct supply despite attempts to “embellish” it Following its November decision to provide Prolia (denosumab) via exclusive direct supply, Amgen has this week announced an update to its commercial offer. Amgen is now offering: Second

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Working with a purpose
Next No getaway for robber with water pistol